These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2293873)

  • 1. Intratumor administration of beta-interferon in recurrent malignant gliomas. A phase I clinical and laboratory study.
    Fetell MR; Housepian EM; Oster MW; Cote DN; Sisti MB; Marcus SG; Fisher PB
    Cancer; 1990 Jan; 65(1):78-83. PubMed ID: 2293873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of recombinant interferon beta (IFN-beta ser) in patients with recurrent glioma.
    Yung WK; Castellanos AM; Van Tassel P; Moser RP; Marcus SG
    J Neurooncol; 1990 Aug; 9(1):29-34. PubMed ID: 2082958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic beta-interferon therapy for recurrent gliomas: a brief report.
    Mahaley MS; Dropcho EJ; Bertsch L; Tirey T; Gillespie GY
    J Neurosurg; 1989 Nov; 71(5 Pt 1):639-41. PubMed ID: 2809717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of recombinant interferon-beta (IFN-beta ser) in patients with diffuse mesothelioma: a Southwest Oncology Group study.
    Von Hoff DD; Metch B; Lucas JG; Balcerzak SP; Grunberg SM; Rivkin SE
    J Interferon Res; 1990 Oct; 10(5):531-4. PubMed ID: 2273299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of interferon-beta-serine in metastatic renal cell carcinoma.
    Kinney P; Triozzi P; Young D; Drago J; Behrens B; Wise H; Rinehart JJ
    J Clin Oncol; 1990 May; 8(5):881-5. PubMed ID: 2332772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of a combination of interferon-beta ser and interferon-gamma in patients with advanced malignant melanoma.
    Schiller JH; Storer B; Bittner G; Willson JK; Borden EC
    J Interferon Res; 1988 Oct; 8(5):581-9. PubMed ID: 3148669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections.
    Miles SA; Wang HJ; Cortes E; Carden J; Marcus S; Mitsuyasu RT
    Ann Intern Med; 1990 Apr; 112(8):582-9. PubMed ID: 2109563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of combinations of recombinant interferons beta(ser) and gamma in patients with advanced malignancy.
    Schiller JH; Storer B; Willson JK; Borden EC
    Cancer Treat Rep; 1987 Oct; 71(10):945-52. PubMed ID: 3115570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
    Schiller JH; Storer B; Paulnock DM; Brown RR; Datta SP; Witt PL; Borden EC
    J Clin Invest; 1990 Oct; 86(4):1211-21. PubMed ID: 2120284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human biologic response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-beta serine.
    Goldstein D; Sielaff KM; Storer BE; Brown RR; Datta SP; Witt PL; Teitelbaum AP; Smalley RV; Borden EC
    J Natl Cancer Inst; 1989 Jul; 81(14):1061-8. PubMed ID: 2472488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of recombinant beta ser 17 interferon in the treatment of cancer.
    Sarna G; Pertcheck M; Figlin R; Ardalan B
    Cancer Treat Rep; 1986 Dec; 70(12):1365-72. PubMed ID: 3791249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant interferon beta: a phase I-II trial in children with recurrent brain tumors.
    Allen J; Packer R; Bleyer A; Zeltzer P; Prados M; Nirenberg A
    J Clin Oncol; 1991 May; 9(5):783-8. PubMed ID: 2016620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biological effects of recombinant interferon-beta administered intravenously daily in phase I trial.
    Borden EC; Hawkins MJ; Sielaff KM; Storer BM; Schiesel JD; Smalley RV
    J Interferon Res; 1988 Jun; 8(3):357-66. PubMed ID: 3045221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced in vitro growth suppression of human glioblastoma cultures treated with the combination of recombinant fibroblast and immune interferons.
    Vita JR; Edwalds GM; Gorey T; Housepian EM; Fetell MR; Guarini L; Langer JA; Fisher PB
    Anticancer Res; 1988; 8(3):297-302. PubMed ID: 2839097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal interferon-beta: sustained release treatment of simian varicella virus infection in monkeys.
    Eppstein DA; Van der Pas MA; Gloff CA; Soike KF
    J Infect Dis; 1989 Apr; 159(4):616-20. PubMed ID: 2538517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-alpha. Results of a phase I clinical trial.
    Merchant RE; McVicar DW; Merchant LH; Young HF
    J Neurooncol; 1992 Jan; 12(1):75-83. PubMed ID: 1541981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of betaseron (beta ser17-interferon) as treatment of advanced malignant melanoma.
    Sarna GP; Figlin RA; Pertcheck M
    J Biol Response Mod; 1987 Aug; 6(4):375-8. PubMed ID: 3625229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance and efficacy of intranasal administration of recombinant beta serine interferon in healthy adults.
    Sperber SJ; Levine PA; Innes DJ; Mills SE; Hayden FG
    J Infect Dis; 1988 Jul; 158(1):166-75. PubMed ID: 2839579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of 125I-labeled recombinant beta interferon (IFN-beta Ser17) to human cells.
    O'Rourke EC; Drummond RJ; Creasey AA
    Mol Cell Biol; 1984 Dec; 4(12):2745-9. PubMed ID: 6441889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and adverse effects of beta-interferon in the treatment of malignant glioma].
    Oda Y; Konishi T; Suzui H; Kamijo Y; Kang Y; Okumura T; Kaneko T; Kikuchi H
    Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2411-7. PubMed ID: 2614179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.